User's Guide |
iCell Cardiomyocytes
|
Application Protocols |
Immunofluorescent Labeling |
Modeling Cardiac Hypertrophy: |
|
Modeling Cardiac Hypertrophy: |
|
Modeling Cardiac Hypertrophy: |
|
Modeling Cardiac Hypertrophy: |
|
Multielectrode Array System |
|
Performing Perforated Patch Clamp |
|
Total RNA Extraction |
|
Using Transfection for siRNA Delivery |
|
| xCELLigence RTCA Cardio System |
|
|
Performing Bioenergetic Analysis: |
|
Material Safety Data Sheets (MSDS) |
iCell Cardiomyocytes
|
iCell Cardiomyocytes Plating Medium
|
|
|
iCell Cardiomyocytes Maintenance Medium
|
|
iCell Cardiomyocytes |
|
Add-Mix-Read Assays for Assessing Cell Health Using an iPSC-derived Cardiomyocyte Cell Model
|
|
Applying Transfection Technologies to Create Novel Screening Models
|
|
Assaying Caspase Activity & Apoptosis
|
|
|
Assaying Cell Viability
|
Assaying Cytotoxicity
|
|
|
Assaying Mitochondrial Membrane Potential
|
|
|
Whitepapers |
Use of Pluripotent Stem Cell-derived Cardiomyocytes to Understand Mechanisms of Cardiotoxic Compounds |
Presentations |
Induced Pluripotent Stem Cell-derived Tissues and their Role in Developing Novel Assays for Drug Discovery
|
Human Induced Pluripotent Stem Cell Derived Cardiomyocytes Are a More Relevant Model Than H9C2 Cells for Assessing Mitochondrial Function in Drug Discovery and Toxicity Screens |
|
Quantification of Cardioactive Drug Effects Using xCELLigence RTCA Cardio and Human iPS-derived Cardiomyocytes |
|
What Makes a Cardiomyocyte a Cardiomyocyte? |
|
Application of iPS Cell-derived Cells and a Novel Electrophysiology Platform for Neuronal and Cardiac Toxicity Evaluation and Drug Screening |
|
|
Advanced Assays for In Vitro Toxicity Evaluation and Phenotypic Screening |
|
Advancements in the Use of iPS Cell-derived Cells for In Vitro Disease Modeling and Phenotypic Screening |
|
|
Human iPS Cell Technology in Predictive and Mechanism-based Drug Discovery and Toxicity Testing Using Photometric-Based Assays |
Novel Assays for Drug Discovery and Toxicology Using Human iPS Cell-derived Neurons and Cardiomyocytes |
|
Large-Scale Production of Human iPS Cell-derived Cardiomyocytes |
|
Predictive Analysis of Cell Viability, Apoptosis and ADME/Tox Properties Using Multiparametric in vivo Assays and Human Induced Pluripotent Stem (iPS) Cell-derived Cardiomyocytes and Hepatocytes |
|
| Predictive Multiparametric in vitro Assay Combinations for Cytotoxicity, Viability, Apoptosis, and ADME Applications with Hepatocytes and Human Stem Cell-derived Cardiomyocytes |
|
Stem Cell Toxicology and Drug Discovery: iCell Cardiomyocytes plus Molecular Devices Screening Platforms |
|
Toxicology in the 21st Century: Stem Cells in Drug Discovery and Development |
|
Bibliography |
Published Research |
Posters |
Application of Human iPS Cell-derived Models for Highly Predictive Toxicity Screening |
|
Development and Characterization of Human Induced Pluripotent Stem Cell-Derived Model Systems for |
|
|
iCell® Cardiomyocytes: Human iPSC-derived Cardiomyocytes for Fully Functional and |
|
Multiparameter In Vitro Assessment of Drug Effects on Cardiomyocyte Physiology Using iPS Cells |
Optical Measurements of Electrical Activity from hiPSC-derived Cardiomyocytes Is a Robust and High-throughput Method for Measuring NCE-effects on the Cardiac Action Potential |
|
Applications Development at CDI: Improving Workflows, Pushing Biology, and Enabling Screening |
|
| Human iPSC-derived Cells for Modelling Cellular Bioenergetics: Building a Metabolic Profile Using the XF Mito Stress Test |
|
Advancements in the Use of iPS Cell-derived Systems for In Vitro Disease Modeling and Phenotypic Screening |
|
|
Implementation of Human iPSC-derived Cell Types Into High Throughput Screening Workflows |
|
Datasheet |
iCell Endothelial Cells |
Application Notes |
Applying Transfection Technologies to Create Novel Screening Models
|
|
iCell Endothelial Cells - Assaying Cell Proliferation |
iCell Endothelial Cells - Assaying Barrier Function |
|
Poster |
|
|
Application of Human iPS Cell-derived Models for Highly Predictive Toxicity Screening |
Applications Development at CDI: Improving Workflows, Pushing Biology, and Enabling Screening |
|
| Human iPSC-derived Cells for Modelling Cellular Bioenergetics: Building a Metabolic Profile Using the XF Mito Stress Test |
|
Advancements in the Use of iPS Cell-derived Systems for In Vitro Disease Modeling and Phenotypic Screening |
|
|
Implementation of Human iPSC-derived Cell Types Into High Throughput Screening Workflows |
|
Datasheet |
iCell Hepatocytes |
Presentations |
Induced Pluripotent Stem Cell-derived Tissues and their Role in Developing Novel Assays for Drug Discovery
|
|
Advanced Assays for In Vitro Toxicity Evaluation and Phenotypic Screening |
|
|
Human iPS Cell Technology in Predictive and Mechanism-based Drug Discovery and Toxicity Testing Using Photometric-Based Assays |
Posters |
Application of Human iPS Cell-derived Models for Highly Predictive Toxicity Screening |
|
In Vitro Assessment of Drug Induced Liver Injury (DILI) Using a High Content Cellular Imaging System |
|
Characterization and Function of iPSC derived Hepatocytes for Use in Toxicity
|
Comparison of Two Cell Model Systems, Primary Human Hepatocytes and hiPSC-derived Hepatocytes to Determine the Hepatoxicity of Three Candidate Drugs Developed for Rheumatoid Arthritis |
|
Predictive High-Content/High-Throughput Assays for Hepatotoxicity Using Induced Pluripotent Stem Cell (iPSC)-derived Hepatocytes |
|
Applications Development at CDI: Improving Workflows, Pushing Biology, and Enabling Screening |
|
| Human iPSC-derived Cells for Modelling Cellular Bioenergetics: Building a Metabolic Profile Using the XF Mito Stress Test |
|
Advancements in the Use of iPS Cell-derived Systems for In Vitro Disease Modeling and Phenotypic Screening |
|
|
Implementation of Human iPSC-derived Cell Types Into High Throughput Screening Workflows |
|
User's Guide |
iCell Neurons
|
Application Protocols |
Assessing Neurite Outgrowth Using High Content Screening |
| Immunofluorescent Labeling |
|
|
Multielectrode Array System Application Protocol |
|
|
Plating into 1536-well Cell Culture Plates |
|
|
|
|
|
Performing Bioenergetic Analysis: |
|
Material Safety Data Sheets (MSDS) |
iCell Neurons |
iCell Neurons Maintenance Medium
|
|
|
iCell Neurons Medium
Supplement |
|
Datasheet |
iCell Neurons |
Application Notes |
Applying Transfection Technologies to Create Novel Screening Models
|
Presentations |
Induced Pluripotent Stem Cell-derived Tissues and their Role in Developing Novel Assays for Drug Discovery
|
|
Application of iPS Cell-derived Cells and a Novel Electrophysiology Platform for Neuronal and Cardiac Toxicity Evaluation and Drug Screening |
|
Advanced Assays for In Vitro Toxicity Evaluation and Phenotypic Screening |
|
Advancements in the Use of iPS Cell-derived Cells for In Vitro Disease Modeling and Phenotypic Screening |
|
Characterizing Human iPS Cell-derived Neuronal Cultures: Expression and Function of Ion Channels and Receptors |
|
Novel Assays for Drug Discovery and Toxicology Using Human iPS Cell-derived Neurons and Cardiomyocytes |
|
Bibliography |
Published Research |
Posters |
Application of Human iPS Cell-derived Models for Highly Predictive Toxicity Screening |
|
Development and Characterization of Human Induced Pluripotent Stem Cell-Derived Model Systems for |
|
|
Applications of Human iPSC-derived Neurons Using High-content Image-based Assays |
|
Development and Characterization of Human iPSC-derived Neurons for Drug Discovery Applications |
High Content Neuronal Toxicity Assays Using iPS Cell-derived Neurons |
|
Evaluation of Network Electrophysiology for Neurotoxicity Screening |
|
Optimization of Neuronal Cultures Derived from Human Induced Pluripotent Stem Cells for High Throughput Assays of Synaptic Function |
|
Applications Development at CDI: Improving Workflows, Pushing Biology, and Enabling Screening |
|
| Human iPSC-derived Cells for Modelling Cellular Bioenergetics: Building a Metabolic Profile Using the XF Mito Stress Test |
|
Advancements in the Use of iPS Cell-derived Systems for In Vitro Disease Modeling and Phenotypic Screening |
|
|
Implementation of Human iPSC-derived Cell Types Into High Throughput Screening Workflows |
|